Melexis Balance Sheet Health
Financial Health criteria checks 5/6
Melexis has a total shareholder equity of €604.9M and total debt of €187.6M, which brings its debt-to-equity ratio to 31%. Its total assets and total liabilities are €897.1M and €292.1M respectively. Melexis's EBIT is €253.8M making its interest coverage ratio 41.8. It has cash and short-term investments of €34.7M.
Key information
31.0%
Debt to equity ratio
€187.61m
Debt
| Interest coverage ratio | 41.8x |
| Cash | €34.69m |
| Equity | €604.95m |
| Total liabilities | €292.11m |
| Total assets | €897.06m |
Recent financial health updates
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well
Oct 31
Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Recent updates
Melexis (EBR:MELE) Knows How To Allocate Capital Effectively
Dec 26Improved Earnings Required Before Melexis NV (EBR:MELE) Shares Find Their Feet
Nov 29These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well
Oct 31Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 11Should You Think About Buying Melexis NV (EBR:MELE) Now?
Oct 01Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Aug 31There's Reason For Concern Over Melexis NV's (EBR:MELE) Price
Aug 19Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Aug 02A Look At The Fair Value Of Melexis NV (EBR:MELE)
Jul 04Is There Now An Opportunity In Melexis NV (EBR:MELE)?
Jun 20Melexis (EBR:MELE) Knows How To Allocate Capital
Jun 07Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment
May 08Calculating The Fair Value Of Melexis NV (EBR:MELE)
Mar 27At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Mar 14Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital
Feb 28Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02What Does Melexis NV's (EBR:MELE) Share Price Indicate?
Dec 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Nov 27Melexis (EBR:MELE) Knows How To Allocate Capital
Nov 15Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)
Nov 03Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 10Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Sep 26Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Sep 02Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Aug 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Aug 05Melexis (EBR:MELE) Might Become A Compounding Machine
Jul 13Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?
Jun 29Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)
Jun 02At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Apr 11With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case
Mar 27Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jan 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Dec 24Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 24Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 18Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 04Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 20We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease
Sep 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 05Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Aug 22Melexis (EBR:MELE) Will Pay A Dividend Of €0.91
Aug 04Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?
Jul 11Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Jun 27Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?
Jun 13Should You Think About Buying Melexis NV (EBR:MELE) Now?
Mar 01Calculating The Fair Value Of Melexis NV (EBR:MELE)
Feb 14Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Dec 06Financial Position Analysis
Short Term Liabilities: MELE's short term assets (€474.5M) exceed its short term liabilities (€92.7M).
Long Term Liabilities: MELE's short term assets (€474.5M) exceed its long term liabilities (€199.4M).
Debt to Equity History and Analysis
Debt Level: MELE's net debt to equity ratio (25.3%) is considered satisfactory.
Reducing Debt: MELE's debt to equity ratio has increased from 18.4% to 31% over the past 5 years.
Debt Coverage: MELE's debt is well covered by operating cash flow (90.2%).
Interest Coverage: MELE's interest payments on its debt are well covered by EBIT (41.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 04:27 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Melexis NV is covered by 26 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robin van den Broek | ABN AMRO Bank N.V. |
| Jean-Marie Caucheteux | Banque Degroof |
| Trion Reid | Berenberg |